BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Brain and Spinal Cord Cancer
NCI Information
Our Treatment Approach
Clinical Trials
Support Groups
Effects of Treatment
Videos and Podcasts
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201209125
Principal Investigator:
Tran, David
Title:
A Phase II Study of Rindopepimut/GM-CSF in Patients with Relapsed EGFRvIII-Positive Glioblastoma (CDX110-06)
Phase:
II
Disease Site:
Brain and Central Nervous System
Participating Site(s):
Main Campus
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research study is to find out whether adding rindopepimut and GM-CSF to bevacizumab helps to shrink brain tumors, prevent brain tumors from growing, or help patients with brain tumors live longer than treatment with bevacizumab alone.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)